MaxCyte, Inc. (NASDAQ:MXCT – Get Free Report) Director John Joseph Johnston sold 3,000 shares of the firm's stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $3.82, for a total value of $11,460.00. Following the completion of the…
